BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kanda T, Ishikawa T, Kosugi SI, Ueki K, Naito T, Wakai T, Hirota S. Prognostic factors after imatinib secondary resistance: survival analysis in patients with unresectable and metastatic gastrointestinal stromal tumors. Int J Clin Oncol 2016;21:295-301. [PMID: 26386705 DOI: 10.1007/s10147-015-0903-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
Number Citing Articles
1 Kanda T, Masuzawa T, Hirai T, Ikawa O, Takagane A, Hata Y, Ojima H, Sodeyama H, Mochizuki I, Ishikawa T, Kagimura T, Nishida T. Surgery and imatinib therapy for liver oligometastasis of GIST: a study of Japanese Study Group on GIST. Jpn J Clin Oncol 2017;47:369-72. [PMID: 28073945 DOI: 10.1093/jjco/hyw203] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Kikuchi H, Hiramatsu Y, Kamiya K, Morita Y, Sakaguchi T, Konno H, Takeuchi H. Surgery for metastatic gastrointestinal stromal tumor: to whom and how to? Transl Gastroenterol Hepatol 2018;3:14. [PMID: 29682621 DOI: 10.21037/tgh.2018.02.02] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]